Analysts expect Xylem Inc. (NYSE:XYL) to report $1.28 billion in sales for the current quarter, according to Zacks. Seven analysts have issued estimates for Xylem’s earnings, with the lowest sales estimate coming in at $1.26 billion and the highest estimate coming in at $1.29 billion. Xylem posted sales of $1.10 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 16.4%. The business is scheduled to announce its next earnings report on Thursday, February 1st.

On average, analysts expect that Xylem will report full-year sales of $1.28 billion for the current year, with estimates ranging from $4.69 billion to $4.72 billion. For the next fiscal year, analysts anticipate that the company will post sales of $4.97 billion per share, with estimates ranging from $4.88 billion to $5.10 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover Xylem.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.01. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The company had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.18 billion. During the same quarter in the previous year, the business earned $0.54 earnings per share. The firm’s revenue for the quarter was up 33.2% on a year-over-year basis.

A number of research analysts have recently issued reports on XYL shares. Royal Bank Of Canada reissued an “outperform” rating and issued a $71.00 target price (up previously from $64.00) on shares of Xylem in a report on Wednesday, October 4th. Canaccord Genuity reissued a “hold” rating and issued a $56.00 target price on shares of Xylem in a report on Friday, October 6th. Stifel Nicolaus reissued a “hold” rating and issued a $63.00 target price on shares of Xylem in a report on Friday, October 13th. Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a report on Thursday, October 5th. Finally, Oppenheimer reissued a “buy” rating on shares of Xylem in a report on Tuesday, October 31st. Six research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $65.17.

In related news, insider Colin R. Sabol sold 38,070 shares of the company’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $65.81, for a total transaction of $2,505,386.70. Following the transaction, the insider now owns 61,979 shares of the company’s stock, valued at $4,078,837.99. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven R. Loranger sold 37,700 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $66.25, for a total value of $2,497,625.00. Following the transaction, the director now directly owns 58,831 shares in the company, valued at approximately $3,897,553.75. The disclosure for this sale can be found here. Insiders have sold 83,270 shares of company stock worth $5,501,312 in the last ninety days. 0.75% of the stock is currently owned by corporate insiders.

Several large investors have recently modified their holdings of XYL. Louisiana State Employees Retirement System grew its stake in shares of Xylem by 0.9% in the second quarter. Louisiana State Employees Retirement System now owns 11,100 shares of the industrial products company’s stock valued at $615,000 after buying an additional 100 shares in the last quarter. Strs Ohio grew its stake in Xylem by 6.2% during the 2nd quarter. Strs Ohio now owns 21,049 shares of the industrial products company’s stock valued at $1,166,000 after purchasing an additional 1,232 shares in the last quarter. NGAM Advisors L.P. grew its stake in Xylem by 57.5% during the 2nd quarter. NGAM Advisors L.P. now owns 21,669 shares of the industrial products company’s stock valued at $1,201,000 after purchasing an additional 7,911 shares in the last quarter. CIBC Asset Management Inc grew its stake in Xylem by 0.3% during the 2nd quarter. CIBC Asset Management Inc now owns 17,671 shares of the industrial products company’s stock valued at $980,000 after purchasing an additional 58 shares in the last quarter. Finally, Daiwa Securities Group Inc. grew its stake in Xylem by 380.3% during the 2nd quarter. Daiwa Securities Group Inc. now owns 103,500 shares of the industrial products company’s stock valued at $5,737,000 after purchasing an additional 81,950 shares in the last quarter. Institutional investors and hedge funds own 85.58% of the company’s stock.

Shares of Xylem (XYL) traded down $0.24 during midday trading on Tuesday, reaching $68.77. The company’s stock had a trading volume of 825,600 shares, compared to its average volume of 1,208,648. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.26 and a current ratio of 1.76. Xylem has a one year low of $46.67 and a one year high of $69.88. The stock has a market capitalization of $12,394.20, a PE ratio of 30.14, a P/E/G ratio of 1.92 and a beta of 1.17.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Thursday, November 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend is Wednesday, November 1st. Xylem’s dividend payout ratio is presently 41.86%.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/05/1-28-billion-in-sales-expected-for-xylem-inc-xyl-this-quarter-2.html.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.